Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase

Journal of Molecular Neuroscience

Volumn 21, Issue 3, 2003, Pages 199-212

  Cohen, Osnat ^a   Reichenberg, Abraham ^a,c   Perry, Chava ^a   Ginzberg, Dalia ^a   Pollmächer, Thomas ^b   Soreq, Hermona ^a   Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholinesterase; Cortisol; Cytokines; Declarative memory; Endotoxin; Inflammation; Working memory

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE R; CYTOKINE; ENDOTOXIN; HYDROCORTISONE; ISOENZYME; MESSENGER RNA; SALMONELLA ENDOTOXIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHOLINERGIC ACTIVITY; COGNITION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNE SYSTEM; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NORMAL HUMAN; PSYCHOPHYSIOLOGY; RNA CLEAVAGE; STRESS; VASCULAR ENDOTHELIUM; WORKING MEMORY;

ACETYLCHOLINESTERASE; BIOLOGICAL MARKERS; CYTOKINES; ENDOTOXINS; HUMANS; HYDROCORTISONE; MALE; MEMORY; MEMORY DISORDERS; NEUROIMMUNOMODULATION; PEPTIDE FRAGMENTS; REACTION TIME; RNA, MESSENGER; STRESS;

SALMONELLA;

EID: 3242722725     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:21:3:199     Document Type: Article

References (74)

1. American Psychiatric Association. (1994) Diagnostic and Statistical Manual for Mental Disorders, 4th ed, Washington, DC.
2. Arendt T. (2001) Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 102, 723-765.
3. Baddeley A. (1992) Working memory. Science 255, 556-229.
4. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., et al. (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071.
5. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J. P., et al. (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69, 2441-2451.
6. Bernik T. R., Friedman S. G., Ochani M., DiRaimo R., Ulloa L., Yang H., et al. (2002) Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781-788.
7. Borovikova L. V., Ivanova S., Zhang M., Yang H., Botchkina G. I., Watkins L. R., et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405, 458-462.
8. Burrell R. (1994) Human responses to bacterial endotoxin. Circ. Shock. 43, 137-153.
9. Cabeza R. and Nyberg L. (2000) Imaging cognition II: An empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12, 1-47.
10. Capuron L., Lamarque D., Dantzer R., and Goodall G. (1999) Attentional and mnemonic deficits associated with infectious disease in humans. Psychol. Med. 29, 291-297.
11. Capuron L., Ravaud A., and Dantzer R. (2001) Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom. Med. 63, 376-386.
12. Chen J. M., Dando P. M., Rawlings N. D., Brown M. A., Young N. E., Stevens R. A., et al. (1997) Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272, 8090-8098.
13. Cohen O., Erb C., Ginzberg D., Pollak Y., Seidman S., Shoham S., Yirmiya R., et al. (2002) Neuronal overexpression of 'readthrough' acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psychiatry 7, 874-885.
14. de Quervain D. J., Roozendaal B., Nitsch R. M., McGaugh J. L., and Hock C. (2000) Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat. Neurosci. 3, 313-314.
15. Erb C., Troost J., Kopf S., Schmitt U., Loffelholz K., Soreq H., and Klein J. (2001) Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77, 638-646.
16. Fahmi H. and Chaby R. (1994) Differential recovery of macrophages from endotoxin-tolerant states elicited by lipopolysaccharide and enzymatic treatments. Immunol. Invest. 23, 243-258.
17. Furey M. L., Pietrini P., and Haxby J. V. (2000) Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290, 2315-2319.
18. Gibertini M. (1996) IL1 beta impairs relational but not procedural rodent learning in a water maze task. Adv. Exp. Med. Biol. 402, 207-217.
19. Goodman J. C., Robertson C. S., Grossman R. G., and Narayan R. K. (1990) Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30, 213-217.
20. Green P. and Allen L. M. (1995) Manual for the CogniSyst Story Recall Test. CogniSyst Inc., Durham, NC.
21. Grisaru D., Deutsch V., Shapira M., Pick M., Sternfeld M., Melamed-Book N., et al. (2001) ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol. Med. 7, 93-105.
22. Harder J. A., Baker H. F., and Ridley R. M. (1998) The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys. Brain Res. Bull. 45, 319-326.
23. Hasselmo M. E., Wyble B. P., and Wallenstein G. V. (1996) Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus. 6, 693-708.
24. Hauss-Wegrzyniak B., Vraniak P. D., and Wenk G. L. (2000) LPS-induced neuroinflammatory effects do not recover with time. Neuroreport. 11, 1759-1763.
25. Heeschen C., Weis M., Aicher A., Dimmeler S., and Cooke J. P. (2002) A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J. Clin. Invest. 110, 527-536.
26. Helmstaedter C., Grunwald T., Lehnertz K., Gleissner U., and Elger C. E. (1997) Differential involvement of left temporolateral and temporomesial structures in verbal declarative learning and memory: evidence from temporal lobe epilepsy. Brain Cogn. 35, 110-131.
27. Kaufer D., Friedman A., Seidman S., and Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
28. Kim J. J. and Diamond D. M. (2002) The stressed hippocampus, synaptic plasticity and lost memories. Nat. Rev. Neurosci. 3, 453-462.
29. Kirschbaum C., Wolf O. T., May M., Wippich W., and Hellhammer D. H. (1996) Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 58, 1475-1483.
30. Levin E. D. and Simon B. B. (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl). 138, 217-230.
31. Linthorst A. C., Flachskamm C., Holsboer F., and Reul J. M. (1996) Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway. Neuroscience 72, 989-997.
32. Lupien S. J., Nair N. P., Briere S., Maheu F., Tu M. T., Lemay M., et al. (1999) Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10, 117-139.
33. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., et al. (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10, 313-318.
34. Maier S. F. and Watkins L. R. (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105, 83-107.
35. McCaffrey R. J. and Lynch J. K. (1992) A methodological review of "method skeptic" reports. Neuropsychol. Rev. 3, 235-248.
36. McGeer P. L. and McGeer E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
37. Meshorer E., Erb C., Gazit R., Pavlovsky L., Kaufer D., Friedman A., et al. (2002) Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295, 508-512.
38. Meyers C. A. (1999) Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv. Exp. Med. Biol. 461, 75-81.
39. Mullington J., Korth C., Hermann D. M., Orth A., Galanos C., Holsboer F., et al. (2000) Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R947-R955.
40. Navia B. A., Jordan B. D., and Price R. W. (1986) The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19, 517-524.
41. Norusis M. J. (1994) SPSS Advanced Statistics 6.1. SPSS Inc., Chicago, IL.
42. Ogura H., Kosasa T., Kuriya Y., and Yamanishi Y. (2000) Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find Exp. Clin. Pharmacol. 22, 89-95.
43. Oitzl M. S., van Oers H., Schobitz B., and de Kloet E. R. (1993) Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res. 613, 160-163.
44. Owen A. M., Morris R. G., Sahakian B. J., Polkey C. E., and Robbins T. W. (1996) Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdala-hippocampectomy in man. Brain 119, 1597-1615.
45. Palmer A. M. (2002) Pharmacotherapy for Alzheimer's disease: progress and prospects. Trends Pharmacol. Sci. 23, 426-433.
46. Perry C., Sklan E., Birikh K., Shapira M., Trejo L., Eldor A., et al. (2002) Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21, 8428-8441.
47. Pollmacher T., Mullington J., Korth C., Schreiber W., Hermann D., Orth A., et al. (1996) Diurnal variations in the human host response to endotoxin. J. Infect. Dis. 174, 1040-1045.
48. Pugh C. R., Kumagawa K., Fleshner M., Watkins L. R., Maier S. F., and Rudy J. W. (1998) Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 12, 212-229.
49. Quirarte G. L., Roozendaal B., and McGaugh J. L. (1997) Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc. Natl. Acad. Sci. USA 94, 14048-14053.
50. Rachal Pugh C., Fleshner M., Watkins L. R., Maier S. F., and Rudy J. W. (2001) The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 25, 29-41.
51. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 58, 445-452.
52. Roberts J. C. and Jones S. B. (1997) Chromaffin cell epinephrine secretion mediated by a macrophage peptide: the role of endotoxin. Shock 7, 211-216.
53. Roozendaal B., Nguyen B. T., Power A. E., and McGaugh J. L. (1999) Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation. Proc. Natl. Acad. Sci. USA 96, 11642-11647.
54. Ruff R. M. and Allen C. C. (1996) Ruff 2 & 7 Selective Attention Test: Professional Manual. Psychological Assessment Resources Inc., Lutz, FL.
55. Saito H., Togashi H., Yoshioka M., Nakamura N., Minami M., and Parvez H. (1995) Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 22, S257-S259.
56. Segal M. and Auerbach J. M. (1997) Muscarinic receptors involved in hippocampal plasticity. Life Sci. 60, 1085-1091.
57. Shapira M., Tur-Kaspa I., Bosgraaf L., Livni N., Grant A. D., Grisaru D., et al. (2000) A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9, 1273-1281.
58. Shaw K. N., Commins S., and O'Mara S. M. (2001) Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav. Brain Res. 124, 47-54.
59. Shohami E., Kaufer D., Chen Y., Seidman S., Cohen O., Ginzberg D., et al. (2000) Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78, 228-236.
60. Soreq H. and Glick D. (2000) Novel roles for cholinesterases in stress and inhibitor responses, in Cholinesterases and Cholinesterase Inhibitors: Basic, Preclinical and Clinical Aspects, Giacobini E., ed., Martin Dunitz, London, pp. 47-61.
61. Soreq H. and Seidman S. (2001) Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2, 294-302.
62. Squire L. R. (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99, 195-231.
63. Stansbury K., Haley D., and Koeneker A. (2000) Higher cortisol values facilitate spatial memory in toddlers. Brief report. Ann. NY Acad. Sci. 911, 456-458.
64. Sternfeld M., Shoham S., Klein O., Flores-Flores C., Evron T., Idelson G. H., et al. (2000) Excess "readthrough" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97, 8647-8652.
65. Tabachnick B. G. and Fidell L. S. (2001) Using Multivariate Statistics, 4th ed, Allyn and Bacon, Boston, MA.
66. Thornton A. E., Raz N., and Tucke K. A. (2002) Memory in multiple sclerosis: contextual encoding deficits. J. Int. Neuropsychol. Soc. 8, 395-409.
67. Tracey K. J., Czura C. J., and Ivanova S. (2001) Mind over immunity. Faseb. J. 15, 1575-1576.
68. Trembovler V., Beit-Yannai E., Younis F., Gallily R., Horowitz M., and Shohami E. (1999) Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat. J. Interferon Cytokine Res. 19, 791-795.
69. Wechsler D. (1987) Wechsler Memory Scale, Revised Manual, The Psychological Corp., San Antonio, TX.
70. Weinstock M. (1995) The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration 4, 349-356.
71. Willard L. B., Hauss-Wegrzyniak B., and Wenk G. L. (1999) Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience. 88, 193-200.
72. Winer B., Brown D., and Michels K. (1991) Statistical Principles in Experimental Design, 3rd ed, McGraw-Hill, New York.
73. Yirmiya R. (1997) Behavioral and psychological effects of immune activation: implications for 'depression due to a general medical condition.' Current Opinion in Psychiatry. 10, 470-476.
74. Zhang Y. H., Lu J., Elmquist J. K., and Saper C. B. (2000) Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord. J. Neurosci. 20, 6578-6586.